Portola Pharmaceuticals, Inc. Increase (Decrease) in Restricted Cash
Portola Pharmaceuticals, Inc. reported Increase (Decrease) in Restricted Cash of -$5.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-01
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $3.00K.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was -$2.00K, a 100.11% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was -$2.00K.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was -$4.00K.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2017 was -$5.00K.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2016 was -$163.00K, a 147.80% decline from fiscal 2015.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2015 was $341.00K.
- Portola Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2011 was -$6.00M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.00K derived: sum of 2 quarters · filed 2018-03-01 | -$1.00K derived: sum of 3 quarters · filed 2018-03-01 | -$5.00K 10-K · filed 2018-03-01 |
| 2017-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$4.00K derived: sum of 2 quarters · filed 2017-11-09 | -$8.00K 10-Q · filed 2017-11-09 | -$1.76M derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$6.00K 10-Q · filed 2017-08-09 | -$1.76M derived: sum of 3 quarters · filed 2018-03-01 | $27.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-03-31 | -$4.00K 10-Q · filed 2017-05-09 | -$1.76M derived: sum of 2 quarters · filed 2018-03-01 | $29.00K derived: sum of 3 quarters · filed 2018-03-01 | -$88.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $33.00K derived: sum of 2 quarters · filed 2018-03-01 | -$84.00K derived: sum of 3 quarters · filed 2018-03-01 | -$163.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.67M derived: sum of 2 quarters · filed 2017-11-09 | $1.59M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$196.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$79.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $341.00K 10-K · filed 2018-03-01 | |||
| 2011-12-31 | -$6.00M 10-K · filed 2014-03-03 |